KW-6356
- Generic Name
- KW-6356
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.
- Associated Conditions
- -
- Associated Therapies
- -
A Through QT/QTc Study of KW-6356
- Conditions
- Interventions
- First Posted Date
- 2020-04-13
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 128
- Registration Number
- NCT04342273
- Locations
- ๐ฏ๐ต
Medical Co. LTA Sumida Hospital, Sumida-ku, Tokyo, Japan
๐ฏ๐ตMedical Co. LTA Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan
Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite
- First Posted Date
- 2019-12-09
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT04190654
- Locations
- ๐บ๐ธ
Clinical Pharmacology of Miami, LLC, Miami, Florida, United States
๐บ๐ธOrlando Clinical Research Center, Orlando, Florida, United States
๐บ๐ธPinnacle Clinical Research, San Antonio, Texas, United States
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356
- First Posted Date
- 2019-11-01
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT04147910
- Locations
- ๐บ๐ธ
Covance Clinical Research Unit Inc., Madison, Wisconsin, United States
A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin
- Conditions
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04070495
- Locations
- ๐ฏ๐ต
Medical Co. LTA Sumida Hospital, Sumida-ku, Tokyo, Japan
A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin
- Conditions
- Interventions
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT03970798
- Locations
- ๐ฏ๐ต
Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
- First Posted Date
- 2018-10-12
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 502
- Registration Number
- NCT03703570
- Locations
- ๐ฏ๐ต
Iwamizawa Neurology Clinic, Iwamizawa, Hokkaido, Japan
A Study of KW-6356 in Subjects With Early Parkinson's Disease
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 175
- Registration Number
- NCT02939391
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.